BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild‐type RAS

E-ISSN： 1096-8652|89|5|499-504

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.89, Iss.5, 2014-05, pp. : 499-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RAS Pathway Mutations in Juvenile Myelomonocytic Leukemia

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 207-211

Karger

Access to resources Recommend Favorite

Circulating tumor cells as a longitudinal biomarker in patients with advanced chemorefractory, RAS‐BRAF wild‐type colorectal cancer receiving cetuximab or panitumumab

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 6, 2015-09 ,pp. : 1467-1474

John Wiley & Sons Inc

Access to resources Recommend Favorite

Additional Chromosome Abnormalities, BCR-ABL Tyrosine Kinase Domain Mutations and Clinical Outcome in Hungarian Tyrosine Kinase Inhibitor-Resistant Chronic Myelogenous Leukemia Patients

Acta Haematologica, Vol. 127, Iss. 1, 2011-10 ,pp. : 34-42

Karger

Access to resources Recommend Favorite

Pleural Effusion in Chronic Myelomonocytic Leukemia

Acta Haematologica, Vol. 99, Iss. 1, 1998-01 ,pp. : 34-37

Karger

Access to resources Recommend Favorite

Leukemia cutis in a patient with chronic myelomonocytic leukemia

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 16, Iss. 1, 2018-01 ,pp. : 81-83

John Wiley & Sons Inc

Access to resources Recommend Favorite